Company Number: 13241293

Analysis Date: 2025-07-29 14:16 UTC

1. Industry Classification: KUMBIL LIMITED is classified under SIC code 86900, which corresponds to "Other human health activities." This sector broadly encompasses healthcare services not specifically categorized under hospitals, medical practices, or dental services, such as specialized outpatient care, health consultancy, or alternative health services. The sector is characterised by high regulatory oversight, reliance on qualified professionals (in this case, the director is a pharmacist), and sensitivity to public health trends and government healthcare policies.

2. Relative Performance: KUMBIL LIMITED is a very small enterprise, with turnover of £5,215 in the latest financial year ending March 2024, down from £7,703 in the previous year. The company reports negligible fixed assets and minimal current assets, with only £1 in cash and no debtors or liabilities recorded in 2024. This contrasts sharply with typical UK small healthcare service providers, which often have turnovers in the tens or hundreds of thousands of pounds and maintain some working capital or tangible assets. The company's operating profit dropped from £4,538 in 2023 to break-even in 2024, indicating minimal business activity or possibly a startup phase with very limited revenue generation. As a micro-entity, KUMBIL is significantly below average sector benchmarks in turnover, asset base, and profitability.

3. Sector Trends Impact: The human health activities sector is currently influenced by several trends: increasing demand for outpatient and specialist services, growing integration of digital health technologies, and challenges related to NHS funding and private healthcare reimbursement rates. Additionally, post-pandemic healthcare priorities have shifted towards preventive and community-based care. KUMBIL’s small scale and minimal financial activity suggest it has yet to capitalize on these trends or may be in an incubation period. Its directorship by a pharmacist could indicate potential niche service offerings, such as pharmaceutical consultancy or patient counselling, which are areas seeing growth due to emphasis on medication management and community health.

4. Competitive Positioning: KUMBIL LIMITED, as a micro-sized private limited company with a single director and minimal financial footprint, is a niche player within the broader human health activities sector. It lacks the scale, resources, and asset base typical of more established competitors in the sector. Strengths include low overheads and potentially flexible service offerings due to its small size and direct professional involvement by a pharmacist. However, weaknesses are evident in its very low turnover, lack of working capital, and absence of tangible or intangible assets, which limit its ability to invest in technology or marketing to grow market share. Additionally, no staff beyond the director is recorded, which may constrain service capacity. In comparison, typical small healthcare enterprises maintain some level of working capital and multiple employees to scale services.